Monoclonal antibody
Type Whole antibody
Source Humanized
Target IL6R
Clinical data
ATC code none
CAS Number 1628814-88-9
ChemSpider none
Chemical and physical data
Formula C1118H1757N315O364S8
Molar mass 256.9 kDa

Vobarilizumab (INN) is a humanized monoclonal antibody designed for the treatment of inflammatory autoimmune diseases.[1][2]

This drug was developed by Ablynx NV.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Vobarilizumab, American Medical Association.
  2. World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 114" (PDF). WHO Drug Information. 29 (4).
This article is issued from Wikipedia - version of the 11/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.